Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for alternative ways to administer anti-obesity drugs. The new, compounded offering ...

The study found that GLP-1-based drugs are effective for weight loss in ... claims database as initiating either denosumab or oral bisphosphonates for osteoporosis. Since fracture morbidity ...

Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...

The company said this drug could be used as a monotherapy or in combination with an oral GLP-1 agonist. The third program is a subcutaneously injected amylin agonist designed to be long-acting.

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

“These drugs are efficacious ... “The emergence of oral formulations and combination therapies may also enhance patient adherence and expand treatment options, highlighting the need for continued ...

In addition, due to increased demand, many GLP-1 agonists are listed on the FDA's Drug Shortages list. People also must consider their comfort level regarding injections, which is the form of ...

Compounders also may prepare compounded versions of a drug on FDA’s drug shortages list if the ... offers access to GLP-1 injections in addition to weight management oral medication kits ...

To foray into the lucrative obesity market, Merck MRK announced that it is in-licensing global rights to an investigational oral ... The GLP-1 segment is a very important class of drugs for ...

Since then, numerous other GLP-1 RA‒based medications have been approved for treating T2D, obesity, and other related conditions, in once-weekly and oral formulations. The new generic approval ...